Concepedia

Christopher Raybuck

CR

Statistics

Publications

1

Citations

27

H-Index

1

Active since

2019

Affiliations

Washington University in St. Louis(Current)

Christopher Raybuck is an author at Washington University in St. Louis specializing in extracellular signal-regulated kinase pathway, mek inhibitors, and cell signaling.

Publications per year

2019–2019

1

Publications

1

Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple‐negative breast cancer

Thomas D. Wright, Christopher Raybuck, Akshita B. Bhatt et al. · Journal of Cellular Biochemistry · 2019 · 27 citations · Full text

, , +17

1–1 of 1